Glutamine synthetase functions as a negative growth regulator in glioma

Journal of Neuro-Oncology

Volumn 114, Issue 1, 2013, Pages 59-69

  Yin, Ying ^a,b   Sun, Weifeng ^a   Xiang, Jie ^b   Deng, Lingxiao ^c   Zhang, Bin ^a,b   Xie, Ping ^a,b   Qiao, Weizhen ^a,b   Zou, Jian ^a,b   Liu, Chunxing ^d  

^a NANJING MEDICAL UNIVERSITY   (China)

^b Wuxi Clinical Science Research Institute   (China)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Shanghai Huadong Sanitarium ^*  (China)

Author keywords

Cell cell contact; Glioma cell; Glutamine synthetase; Motility; N cadherin; Proliferation

Indexed keywords

CYCLIN D1; GLUTAMATE AMMONIA LIGASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY GC 4; NERVE CELL ADHESION MOLECULE; PROTEIN P21; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL ADHESION; CELL AGGREGATION; CELL CONTACT; CELL INVASION; CELL PROLIFERATION; CELL TRANSDIFFERENTIATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; GENE SILENCING; GLIOMA; GROWTH REGULATION; IN VITRO STUDY; METASTASIS INHIBITION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT;

ANIMALS; CELL ADHESION; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOMA; GLUTAMATE-AMMONIA LIGASE; GLUTAMINE; GREEN FLUORESCENT PROTEINS; KI-67 ANTIGEN; NEOPLASM INVASIVENESS; RATS; RNA, SMALL INTERFERING; TIME FACTORS; WOUND HEALING;

EID: 84881157025     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-013-1168-5     Document Type: Article

References (33)

1. Fomchenko EI, Holland EC (2005) Stem cells and brain cancer. Exp Cell Res 306:323-329
2. Zhu Y, Parada LF (2002) The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2:616-626
3. DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114-123
4. Bello L, Giussani C, Carrabba G, Pluderi M, Costa F, Bikfalvi A (2004) Angiogenesis and invasion in gliomas. Cancer Treat Res 117:263-284
5. Kosenko E, Llansola M, Montoliu C, Monfort P, Rodrigo R, Hernandez-Viadel M, Erceg S, Sanchez-Perez AM, Felipo V (2003) Glutamine synthetase activity and glutamine content in brain: modulation by NMDA receptors and nitric oxide. Neurochem Int 43:493-499
6. Robinson SR (2000) Neuronal expression of glutamine synthetase in Alzheimer's disease indicates a profound impairment of metabolic interactions with astrocytes. Neurochem Int 36:471-482
7. Shaked I, Ben-Dror I, Vardimon L (2002) Glutamine synthetase enhances the clearance of extracellular glutamate by the neural retina. J Neurochem 83:574-580
8. Zhuang Z, Qi M, Li J, Okamoto H, Xu DS, Iyer RR, Lu J, Yang C, Weil RJ, Vortmeyer A, Lonser RR (2011) Proteomic identification of glutamine synthetase as a differential marker for oligodendrogliomas and astrocytomas. J Neurosurg 115:789-795
9. Baber Z, Haghighat N (2010) Glutamine synthetase gene expression and glutamate transporters in C6-glioma cells. Metab Brain Dis 25:413-418
10. Vardimon L (2000) Neuroprotection by glutamine synthetase. Isr Med Assoc J 2(Suppl):46-51
11. Zou J, Wang YX, Mu HJ, Xiang J, Wu W, Zhang B, Xie P (2011) Down-regulation of glutamine synthetase enhances migration of rat astrocytes after in vitro injury. Neurochem Int 58:404-413
12. Tsai YJ, Chen IL, Horng LY, Wu RT (2002) Induction of differentiation in rat C6 glioma cells with Saikosaponins. Phytother Res 16:117-121
13. Zou J, Wang YX, Dou FF, Lu HZ, Ma ZW, Lu PH, Xu XM (2010) Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons. Neurochem Int 56:577-584
14. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1:2315-2319
15. Okada S, Nakamura M, Katoh H, Miyao T, Shimazaki T, Ishii K, Yamane J, Yoshimura A, Iwamoto Y, Toyama Y, Okano H (2006) Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury. Nat Med 12:829-834
16. Huang ZY, Wu Y, Hedrick N, Gutmann DH (2003) T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression. Mol Cell Biol 23:566-578
17. Parker KK, Norenberg MD, Vernadakis A (1980) " Transdifferentiation" of C6 glial cells in culture. Science 208:179-181
18. Kazazoglou T, Fleischer-Lambropoulos E, Geladopoulos T, Kentroti S, Stefanis C, Vernadakis A (1996) Differential responsiveness of late passage C-6 glial cells and advanced passages of astrocytes derived from aged mouse cerebral hemispheres to cytokines and growth factors: glutamine synthetase activity. Neurochem Res 21:609-614
19. Moutsatsou P, Kazazoglou T, Fleischer-Lambropoulos H, Psarra AM, Tsiapara A, Sekeris CE, Stefanis C, Vernadakis A (2000) Expression of the glucocorticoid receptor in early and late passage C-6 glioma cells and in normal astrocytes derived from aged mouse cerebral hemispheres. Int J Dev Neurosci 18:329-335
20. Gawronski JD, Benson DR (2004) Microtiter assay for glutamine synthetase biosynthetic activity using inorganic phosphate detection. Anal Biochem 327:114-118
21. Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV (2009) c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458:762-765
22. Su Z, Cao L, Zhu Y, Liu X, Huang Z, Huang A, He C (2007) Nogo enhances the adhesion of olfactory ensheathing cells and inhibits their migration. J Cell Sci 120:1877-1887
23. Asano K, Duntsch CD, Zhou Q, Weimar JD, Bordelon D, Robertson JH, Pourmotabbed T (2004) Correlation of N-cadherin expression in high grade gliomas with tissue invasion. J Neurooncol 70:3-15
24. Gavard J, Marthiens V, Monnet C, Lambert M, Mege RM (2004) N-cadherin activation substitutes for the cell contact control in cell cycle arrest and myogenic differentiation: involvement of p120 and beta-catenin. J Biol Chem 279:36795-36802
25. De Wever O, Westbroek W, Verloes A, Bloemen N, Bracke M, Gespach C, Bruyneel E, Mareel M (2004) Critical role of N-cadherin in myofibroblast invasion and migration in vitro stimulated by colon-cancer-cell-derived TGF-beta or wounding. J Cell Sci 117:4691-4703
26. Diamond ME, Sun L, Ottaviano AJ, Joseph MJ, Munshi HG (2008) Differential growth factor regulation of N-cadherin expression and motility in normal and malignant oral epithelium. J Cell Sci 121:2197-2207
27. Demali KA (2004) Vinculin-a dynamic regulator of cell adhesion. Trends Biochem Sci 29:565-567
28. Grobben B, De Deyn PP, Slegers H (2002) Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion. Cell Tissue Res 310:257-270
29. Saitoh F, Araki T (2010) Proteasomal degradation of glutamine synthetase regulates schwann cell differentiation. J Neurosci 30:1204-1212
30. Stockinger A, Eger A, Wolf J, Beug H, Foisner R (2001) E-cadherin regulates cell growth by modulating proliferation-dependent beta-catenin transcriptional activity. J Cell Biol 154:1185-1196
31. Liu F, Jia L, Thompson-Baine AM, Puglise JM, Ter Beest MB, Zegers MM (2010) Cadherins and Pak1 control contact inhibition of proliferation by Pak1-betaPIX-GIT complex-dependent regulation of cell-matrix signaling. Mol Cell Biol 30:1971-1983
32. George SJ, Dwivedi A (2004) MMPs, cadherins, and cell proliferation. Trends Cardiovasc Med 14:100-105
33. Bendjennat M, Boulaire J, Jascur T, Brickner H, Barbier V, Sarasin A, Fotedar A, Fotedar R (2003) UV irradiation triggers ubiquitin-dependent degradation of p21(WAF1) to promote DNA repair. Cell 114:599-610